Ireland
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 16.88
|
Dec. 31, 2023 | USD 124.37 | -0.54% |
|
Ireland |
|
2 |
USD 12.43
|
Dec. 31, 2023 | USD 199.08 | -1.31% |
|
Ireland |
|
3 |
USD 2.13
|
Dec. 31, 2023 | USD 31.53 | -1.19% |
|
Ireland |
|
4 |
USD 1.25
|
Dec. 31, 2023 | USD 69.87 | -1.17% |
|
Ireland |
|
5 |
USD 0.02
|
Dec. 31, 2023 | USD 0.02 | -0.20% |
|
Ireland |
|
6 |
USD -0.64
|
Dec. 31, 2023 | USD 10.60 | 9.39% |
|
Ireland |
|
7 |
USD -1.60
|
Dec. 31, 2023 | USD 7.90 | 2.73% |
|
Ireland |
|
8 |
USD -2.57
|
Dec. 31, 2023 | USD 14.23 | -3.20% |
|
Ireland |
|
9 |
USD -3.04
|
Dec. 31, 2023 | USD 1.60 | 1.91% |
|
Ireland |
The Clinical Trials company in Ireland with the highest Free Cash Flow Per Share is Jazz Pharmaceuticals plc (NasdaqGS: JAZZ) at USD 16.88.
The Clinical Trials company in Ireland with the lowest Free Cash Flow Per Share is Iterum Therapeutics plc (NasdaqCM: ITRM) at USD -3.04.
The top 10 Clinical Trials companies in Ireland by Free Cash Flow Per Share are Jazz Pharmaceuticals plc, ICON Public Limited Company, Alkermes plc, Cosmo Pharmaceuticals N.V., Ovoca Bio plc, GH Research PLC, Avadel Pharmaceuticals plc, Prothena Corporation plc and Iterum Therapeutics plc.
The bottom 10 Clinical Trials companies in Ireland by Free Cash Flow Per Share are Iterum Therapeutics plc, Prothena Corporation plc, Avadel Pharmaceuticals plc, GH Research PLC, Ovoca Bio plc, Cosmo Pharmaceuticals N.V., Alkermes plc, ICON Public Limited Company and Jazz Pharmaceuticals plc.